期刊文献+

大剂量地塞米松诱导的脑细胞死亡机制 被引量:1

Brain cell death mechanism induced by high-dose dexamethasone
原文传递
导出
摘要 目的探讨大剂量地塞米松诱导的大鼠的脑细胞死亡机制。方法将SD大鼠分为对照组和实验组(包括7、9、11 d,3个时间点)。对照组腹腔注射生理盐水,实验组连续腹腔注射5 mg/kg地塞米松,每日1次。利用光镜和电镜技术观察大脑组织形态结构变化,采用免疫组化和免疫印迹方法检测大脑顶叶皮质Active Caspase-3、PARP-1、pULK1的表达情况。结果 (1)对照组大鼠大脑组织结构清晰,脑细胞排列整齐,形态完整,染色清晰;7d实验组大鼠大脑组织未见明显病理改变;9d实验组部分脑细胞死亡;11d实验组部分脑细胞可见凋亡和胀亡。(2)对照组Active Caspase-3、PARP-1、pULK1均呈阴性表达。与对照组比较,实验组脑细胞胞质内可见明显的Active Caspase-3、pULK1表达,细胞核内可见明显的PARP-1阳性表达,各实验组脑组织内Active Caspase-3、PARP-1、pULK1表达量随着处理时间的延长而增高。结论地塞米松诱导的脑细胞死亡可能通过Active Caspase-3、PARP-1、pULK1的活化所致。 Objective To investigate the brain cell death mechanism induced by high-dose dexamethasone. Methods SD rats were randomly divided into the control group and the experimental group. The experimental group was divided into 7d, 9d, lld three subgroups. The experimental group received intraperitoneal injection of DX 5mg/kg while the control group received injection with equal volume of physiological saline, light microscopy, electron microscopy, immunohistochemistry and western blot were used to observe the morphological changes of the brain tissue and detect the expression of Active Caspase-3, PARP-1, pULK1 of the brain tissue. Results (1) rat brain tissue structure was clear and normal in the control group. In the 7d experimental group, the brain tissue had no significant pathological changes. Apoptosis and oncosis of the brain cells were observed in the 1 ld experimental group. (2) In the control group, expression of active Caspase-3, PARP-1, pULK1 was negative. Compared with the control group, expression levels of active Caspase-3, PARP-1,pULK1 were gradually increased with the treatment time in the brain tissue of the experimental group. Conclusion Brain cell death in dexamethasone-induced may be through the activation of Caspase-3 ,PARP-1, pULK1.
出处 《中国临床解剖学杂志》 CSCD 北大核心 2013年第2期184-187,共4页 Chinese Journal of Clinical Anatomy
基金 辽宁省教育厅计划项目资助(2009A462)
关键词 地塞米松 脑细胞 半胱胺酸蛋白酶蛋白 3 多腺苷二磷酸核糖聚合酶 磷酸化自噬相关蛋白1抗体 Dexamethasone Brain cells Caspase3 Poly(ADP-ribose) polymerase Phospho-ULK1
  • 相关文献

参考文献12

  • 1Baum P, Bercker S, Villmann T, et al.Critical illness myopathy and neuropathy (CRIMYN). Electroneurographic classification [J]. Nervenarzt, 2011,82(4):468-474.
  • 2Hermans G, De Jonghe B, Bruyninckx F, ct al. Clinical review: Critical illness polyneuropathy and myopathy[J].Crit Care, 2008,12(6):238.
  • 3Stevens RD, Hart N, de Jonghe B, et al. Weakness in the ICU: a call to action[J]. Crit Care, 2009,13(6): 1002.
  • 4Mozaffar T, Haddad F, Zeng M, et al. Molecular and cellular detects of skeletal muscle in an animal model of acute quadriplegic myopathy[J]. Muscle Nerve, 2007, 35( I ):55-65.
  • 5Chu X, Fu X, Zou L, et al. Oncosis, the possible cell death pathway in astrocytes after focal cerebral iscbemia [J]. Brain Res, 2007,29 (1149): 157-164.
  • 6Wyllie AH. Apoptosis: cell death in tissue regulation [J]. J Pathol, 1987,153(4): 313-316.
  • 7Kroemer G, EI-Deiry WS, Golstein P, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death[J]. Cell Death Differ, 2005, 12 (suppl 2) : 1463-1467.
  • 8Shimizu S. Apoptosis and non-apoptotic cell death [J]. Rinsho Ketsueki, 2011, 52(10): 1669-1676.
  • 9Wilson MR. Apoptosis: unmasking the executioner[J].Cell Death Differ, 1998,5(8):646-652.
  • 10Andrabi SA, Dawson TM, Dawson VL. Mitochondrial and nuclear cross talk in cell death: parthanatos [J]. Ann N Y Acad Sci, 2008,1147: 233-241.

同被引文献10

  • 1Baum P,Bercker S,Villmann T,et al.Critical illness myopathy and neuropathy (CR -IMYN).Electroneurographic classification[J].Nervenarzt,2011,82(4):468-474.
  • 2Stevens R D,Hart N,de-Jonghe B,et al.Weakness in the ICU:a call to action[J].Crit Care,2009,13(6):1002.
  • 3Schefold JC,Bierbrauer J,Weber-Carstens S.Intensive care unit-acquired weak -ness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock[J].J Cachexia Sarcopenia Muscle,2010,1(2):147-157.
  • 4Yewdell JW,Antonl C,Bennink JR.Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC classⅠmolecules [J] ? J Immunol,1996,157(5):1823-1826.
  • 5Rich MM,Pinter MJ.Crucial role of sodium channel fact inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy[J].J Physiol,2003,547(Pt 2):555-566.
  • 6Ichimura Y,Komatsu M.Selective degradation of p62 by autophagy[J].Semin Immunopathol ,2010,32(4):431-436.
  • 7Myeku N,Figueiredo-Pereira ME.Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome1/p62 [J].J Biol Chem,2011,286(25): 22426-22440.
  • 8黄新敏,张艳霞,万小荣.泛素蛋白的研究进展[J].广东农业科学,2010,37(6):191-194. 被引量:8
  • 9袁静,梁佳,赵颂,包翠芬.地塞米松诱导的危重病性肌病的细胞死亡方式[J].第三军医大学学报,2012,34(5):453-455. 被引量:5
  • 10袁静,梁佳,赵颂,包翠芬.地塞米松诱导的危重病性肌病中PKB/Akt、PKC及NF-κB p65的表达[J].广东医学,2012,33(14):2065-2067. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部